Overview

A Study to Assess the Cognitive Effects of Fesoterodine in Elderly Subjects

Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
The study is designed to evaluate elements of cognitive function in subjects receiving either fesoterodine or alprazolam.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer
Treatments:
Alprazolam
Fesoterodine